Mnemosyne closes on additional $6M in Series A funding

MNEMOSYNE PHARMACEUTICALS INC. closed on an additional $6 million in a Series A financing round, bringing its total Series A funding up to $11.4 million. / COURTESY MNEMOSYNE PHARMACEUTICALS INC.
MNEMOSYNE PHARMACEUTICALS INC. closed on an additional $6 million in a Series A financing round, bringing its total Series A funding up to $11.4 million. / COURTESY MNEMOSYNE PHARMACEUTICALS INC.
PROVIDENCE – Mnemosyne Pharmaceuticals Inc. closed today on an additional $6 million in Series A financing for its drug discovery efforts focused on the identification…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

- Advertisement -